Related Experiment Video
Updated: Mar 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy
1Department of Pediatrics,Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania,United States of America.
Hypertrophic cardiomyopathy (HCM) is a common inherited heart condition. While advances improve outcomes, preventing sudden cardiac death in young individuals with HCM remains a challenge.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart disorder.
- It presents with varied clinical features and disease progression.
- Sudden cardiac death (SCD) is a significant concern, particularly in young individuals.
Purpose of the Study:
- To review key aspects of hypertrophic cardiomyopathy in the young.
- To discuss epidemiology, clinical presentations, and risk factors.
- To explore strategies for preventing sudden cardiac death and managing athletic participation.
Main Methods:
- Literature review and synthesis of current knowledge.
- Analysis of epidemiological data and clinical phenotypes.
- Evaluation of risk stratification and management guidelines.
Main Results:
- HCM affects young individuals with diverse clinical manifestations.
- Risk factors for adverse events, including sudden cardiac death, are identifiable.
- Advances in diagnosis and treatment have reduced adverse events but not eliminated SCD.
Conclusions:
- Comprehensive understanding of HCM in youth is crucial for effective management.
- Risk stratification and targeted prevention strategies are essential.
- Careful consideration of athletic participation is necessary for affected young individuals.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy

